Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.25
Bid: 13.00
Ask: 13.25
Change: 0.55 (4.33%)
Spread: 0.25 (1.92%)
Open: 12.75
High: 13.25
Low: 12.75
Prev. Close: 13.25
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.
3 Apr 18 11:02

Scancell Signs Manufacturing Agreement With PolyPeptide Group

LONDON (Alliance News) - Cancer treatment developer Scancell Holdings PLC said on Tuesday it has signed a manufacturing agreement with therapeutic peptide manufacturer the f T...

Read more
19 Oct 16 11:05

Oxford Technology Venture Capital Funds Suffer Value Drop

...

Read more
10 Oct 16 11:42

Scancell to develop ImmunoBody lung cancer treatment

(ShareCast News) - Cancer immunotherapy development company Scancell Holdings announced on Monday its intention to develop its SCIB2 ImmunoBody for the treatment of non-small cell lung cancer in combi...

Read more
16 Sep 16 14:24

Scancell Holdings widens full year loss on US investment

(ShareCast News) - Scancell Holdings, a developer of novel immunotherapies for the treatment of cancer, has reported a third consecutive full year loss due to the costs involved in its expansion in th...

Read more
31 Aug 16 11:37

Hygea VCT Net Asset Value Drops In Half-Year As Scancell Shares Slide

...

Read more
21 Jul 16 08:32

Scancell Signs SCIB1 Vaccine Manufacturing Deal With Eurogentec

...

Read more
20 Jul 16 12:35

Scancell granted product licence extension from Ichor Medical Systems

(ShareCast News) - Scancell, the developer of immunotherapies for cancer treatments, was granted a product licence option extension from Ichor Medical Systems. The extension is to licence the commerci...

Read more
20 Jul 16 08:30

Scancell Licence To Use TriGrid Technology Extended To 2018 (ALLISS)

...

Read more
13 Jul 16 09:19

Scancell Says Review Supporting Potential Of Moditope Published

...

Read more
6 Jul 16 08:28

Scancell Holdings SCIB1 Cancer Drug Shows "Compelling" Survival Data

...

Read more
17 Jun 16 12:24

Scancell suspends dosing with current supplies of SCIB1 for melanoma

(ShareCast News) - Shares in drug developer Scancell Holdings plunged almost 17% after it suspending dosing with current clinical trial supplies of SCIB1 for melanoma with immediate effect. Patients w...

Read more
17 Jun 16 09:46

WINNERS & LOSERS SUMMARY: National Grid Hit By Break-Up Recommendation

...

Read more
17 Jun 16 08:10

UPDATE 1-Scancell slumps as drug problem disrupts melanoma trial

(Adds latest shares, details) LONDON, June 17 (Reuters) - British drug developer Scancell has suspended dosing in a cancer clinical trial because of quality problems with an immunotherapy treatment,...

Read more
17 Jun 16 07:46

BUZZ-Scancell: drug problem spurs worst day in 3 yrs

** Drug developer Scancell's shares down 27 pct, worst day in nearly three years, after suspends dosing in a cancer clinical trial because of quality problems with its immunotherapy treatment SCIB1 **...

Read more
17 Jun 16 06:51

Drug problem forces Scancell to suspend cancer trial dosing

LONDON, June 17 (Reuters) - British drug developer Scancell said on Friday it was suspending dosing in a cancer clinical trial because of quality problems with its immunotherapy treatment SCIB1. The...

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.